News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|June 19, 2024

Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

Author(s)Derek van Amerongen, MD, MS, Soeren Mattke, MD, DSc, B. Joy Snider, MD, PhD

The panel discusses emerging therapies for Alzheimer disease that are currently in development, including donanemab, subcutaneous lecanemab, and ALZ-801.

Episodes in this series

A panel of 5 experts on Alzheimer disease

EP. 1 The Clinical and Economic Implications of Alzheimer Disease Across Patients, Families, and the Health Care System

B. Joy Snider, MD, PhD, and Maria Lopes, MD, MS

EP. 2 Recent Insights into the Pathophysiology of Alzheimer Disease

A panel of 5 experts on Alzheimer disease

EP. 3 Genetic Aspects of Alzheimer Disease

A panel of 5 experts on Alzheimer disease

EP. 4 The Patient Experience: From Symptoms to Diagnosis of Alzheimer Disease

Video 5 - "Potential Consequences of Early Diagnosis of Alzheimer Disease"

EP. 5 Potential Consequences of Early Diagnosis of Alzheimer Disease

Video 5 - "Potential Consequences of Early Diagnosis of Alzheimer Disease"

EP. 6 Criteria for Diagnosing Alzheimer Disease and the Role of Testing

A panel of experts on Alzheimer's disease

EP. 7 Exploring the Economic Impact of Advanced Approaches for Diagnosing Alzheimer Disease

A panel of experts on Alzheimer's disease

EP. 8 Clinical Impact of the Introduction of Disease-Modifying Treatments for Alzheimer Disease

A panel of experts on Alzheimer's disease

EP. 9 Clinical Decision-Making for Alzheimer Disease Management

A panel of experts on Alzheimer's disease

EP. 10 Cost, Value, and Affordability of Treatment for Alzheimer Disease

A panel of 5 experts on Alzheimer disease

EP. 11 Advancements in Alzheimer Disease Treatment: Emerging Drug Candidates

A panel of 5 experts on Alzheimer disease

EP. 12 Exploring the Influence of Administration Routes on Medical Costs and Caregiver Burden

A panel of 5 experts on Alzheimer disease

EP. 13 Payer Coverage Considerations for New Treatments for Alzheimer Disease

A panel of 5 experts on Alzheimer disease

EP. 14 Concluding Remarks: Impact of Alzheimer Disease, Promising Treatments in Development, and Future Outlook

Video content above is prompted by the following question(s):

Could you discuss disease modifying and other therapies for Alzheimer disease that are currently in development?

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Alzheimer | Image credit: LIGHTFIELD STUDIOS - stock.adobe.com

Atlanta Panel Confronts Bottlenecks in Alzheimer Disease Diagnosis and Care

BySkylar Jeremias

August 17th 2026

Senior man suffering from severe chest pain. Warning signs of unstable angina or myocardrial infarction disease. | Image credit: Orawan - stock.adobe.com

Extended Cooling No Better Than Shorter Duration After Cardiac Arrest

ByPearl Steinzor

August 5th 2026

MRI of the brain | Image Credit: DedMityay - stock.adobe.com

MASLD, MASH Linked to Higher Mild Cognitive Impairment Risk, Lower Dementia Odds

ByBrooke McCormick

July 30th 2026

Brain scan | Image credit: merydolla - stock.adobe.com

Frailty May Signal Elevated Risk of Cognitive Impairment in CKD

ByBrooke McCormick

July 29th 2026

Remote patient monitoring | Image credit: AndSus - stock.adobe.com

Remote Monitoring Captured Between-Visit Symptom Swings in Myasthenia Gravis

BySkylar Jeremias

July 15th 2026

Trending on AJMC

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

5 Things to Know About the FDA's Peptide Reversal

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM